Compare EXLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXLS | RGEN |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | 59500 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 8.2B |
| IPO Year | 2006 | N/A |
| Metric | EXLS | RGEN |
|---|---|---|
| Price | $43.22 | $165.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $54.50 | ★ $174.90 |
| AVG Volume (30 Days) | ★ 1.1M | 618.1K |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.94 | N/A |
| EPS | ★ 1.48 | 0.03 |
| Revenue | ★ $2,026,490,000.00 | $707,890,000.00 |
| Revenue This Year | $15.32 | $17.84 |
| Revenue Next Year | $11.27 | $12.44 |
| P/E Ratio | ★ $29.26 | $5,383.25 |
| Revenue Growth | ★ 14.43 | 11.74 |
| 52 Week Low | $37.30 | $102.97 |
| 52 Week High | $52.43 | $182.52 |
| Indicator | EXLS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 70.43 | 57.69 |
| Support Level | $43.13 | $156.01 |
| Resistance Level | $43.59 | $167.74 |
| Average True Range (ATR) | 0.67 | 4.27 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 83.91 | 81.59 |
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.